Empresa Nextage Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Acciones
NXTG
IL0004330119
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12/08/20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10/07/22 |
General Counsel | 53 | 12/08/20 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 01/01/94 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12/08/20 |
Israel Makov
CHM | Chairman | 85 | 21/11/11 |
Ron Grupel
BRD | Director/Board Member | 73 | 13/10/14 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 12/08/20 |
Orna Dreazen
BRD | Director/Board Member | 69 | 12/08/20 |
Director/Board Member | 59 | 12/08/20 | |
Director/Board Member | 72 | 12/08/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 32 601 972 | 5 226 508 ( 16,03 %) | 0 | 16,03 % |
Información de la empresa
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.ilSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-16,96 % | 11,65 mil M | |
-30,43 % | 2328,01 M | |
-11,81 % | 2201,24 M | |
-23,56 % | 1599,28 M | |
+36,79 % | 1195,22 M | |
-3,28 % | 758 M | |
-12,67 % | 529 M | |
-36,53 % | 475 M | |
+13,72 % | 338 M |